Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

0.420
+0.0205.00%
Volume:69.00K
Turnover:27.87K
Market Cap:259.56M
PE:-0.86
High:0.445
Open:0.445
Low:0.380
Close:0.400
52wk High:5.400
52wk Low:0.330
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:0.76
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.491
ROE:-242.61%
ROA:-20.57%
PB:-2.65
PE(LYR):-0.86
PS:- -

Loading ...

Monkey Prices Have Skyrocketed, Costing Up to 200,000 Yuan Each and Still Hard to Buy? Yet Mount Emei Seems Overrun with Them?

Deep News
·
Jul 26

Innovative Drug Sector Surges: Market Recovery or Reversal? Fund Managers Offer Latest Analysis

Deep News
·
Jul 26

First-in-Class Global Novel Target Drug Achieves Initial Approval in China; Huatai-PineBridge Hang Seng Innovative Drug ETF (520500) Sees Trading Volume Exceed 20 Billion for 15 Consecutive Sessions

Deep News
·
Jul 24

Qingdao Becomes Newest City to Implement National First-Edition Commercial Insurance Innovative Drug List

Deep News
·
Jul 24

Innovative Drug Research Faces a Monkey Shortage: Experimental Monkey Prices Surge to 200,000 Yuan. What Signal Does This Send?

Deep News
·
Jul 24

BeiGene Invests Additional $300 Million in US Expansion, Stock Hits 3-Month High; Hong Kong Stock Connect Innovative Drugs Show Local Strength, 520880 Rises for Third Consecutive Day Against Market

Deep News
·
Jul 24

Grand Pharma's Traditional Chinese Medicine Innovation GPN01360 for Depression Enters Phase III with First Patient Dosed in China

Stock News
·
Jul 23

38 Novel Drugs Achieve Breakthrough, Boosting Sentiment in Innovative Pharma Sector

Deep News
·
Jul 23

Haisco Pharmaceutical's Innovative Drug Succinate Sipukepan Tablets Receive Market Approval

Stock News
·
Jul 23

Innovative Drug Sector Achieves Historic Milestone with Key Approval, ETF Tracks 9 Gains in 10 Sessions

Deep News
·
Jul 22

Novartis Q2 Results Exceed Expectations as Strong Sales of Innovative Drugs Offset Generic Competition, Signaling Return to Growth

Stock News
·
Jul 21

Overseas Expansion, Funding Recovery, and Earnings Growth Drive Low-Valuation Biotech Rebound: A Look at the Hang Seng Innovation Drug ETF

Deep News
·
Jul 21

Innovative Drug Stocks Rebound Swiftly, Leading ETF Surges as Sector Gains Momentum with Positive Developments from Multiple Companies

Deep News
·
Jul 20

Hong Kong Stocks Midday Update: Key Indices Surge, Tech and Oil Shares Lead Gains, Biotech Stocks Show Strength

Deep News
·
Jul 20

Innovative Presbyopia Treatment YUVEZZI™ from Zhaoke Ophthalmology Receives Approval in Macau

Stock News
·
Jul 20

Regulatory Body Reports Over Three Dozen Innovative Drug Approvals in First Half, with Domestic Products Dominating

Deep News
·
Jul 20

Hong Kong Stock Connect Biotech Sector Stages Strong Rebound, Key ETF Surges Over 4%; REMEGEN Announces Buyback, Leading Gains

Deep News
·
Jul 20

Triple Inflection Point Confirmed: Prime Window for Investing in Innovative Drugs Now Open

Deep News
·
Jul 19

Hong Kong Connect Innovative Drug Stocks Plunge Amid Market Turmoil, 520880 ETF Sees Heavy Volume and Premium; A-Share Pharmaceutical Sector Shows Resilience, Only On-Market Pharma ETF Ends Week in the Green

Deep News
·
Jul 19

The Innovative Drug Sector Rally is Far From Over: Four Pillars of Support and a Full Review of Three Key A-Share Tiers

Deep News
·
Jul 17